Regorafenib-Induced Hand–Foot Skin Reaction Is More Severe on the Feet Than on the Hands

Regorafenib is a multikinase inhibitor for the treatment of metastatic colorectal cancer. Regorafenib-induced hand–foot skin reaction (HFSR) is a common side effect during treatment. The reported frequency of HFSR was 80% (grade 3: 28%) in the Japanese subpopulation in the CORRECT trial; however, mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Nonomiya, Yuma, Yokokawa, Takashi, Kawakami, Kazuyoshi, Kobayashi, Kazuo, Aoyama, Takeshi, Takiguchi, Tomomi, Sugisaki, Takahito, Suzuki, Kenichi, Suenaga, Mitsukuni, Wakatsuki, Takeru, Yamaguchi, Kensei, Sugimoto, Yoshikazu, Hama, Toshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848261/
https://www.ncbi.nlm.nih.gov/pubmed/29914591
http://dx.doi.org/10.3727/096504018X15291727589740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848261/
https://www.ncbi.nlm.nih.gov/pubmed/29914591
http://dx.doi.org/10.3727/096504018X15291727589740

Ejemplares similares